BioSenic puts Phase IIb ALLOB trial on hold
INSIDE INFORMATION Prior efficacy unmatched but excellent safety profile confirmed, timing of ALLOB administration for optimal bone repair to...
Source: globenewswire.com
Page 6 - Systemic Sclerosis News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Systemic Sclerosis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Systemic Sclerosis Today - Breaking & Trending Today
BioSenic puts Phase IIb ALLOB trial on hold.
BioSenic puts Phase IIb ALLOB trial on hold.
Source: pharmiweb.com
EULAR SSc Recommendations Now Include Immunosuppressants
The update to 2017 recommendations include targeted synthetic and biologic disease-modifying antirheumatic drugs for the first time.
Source: medscape.com
Patient Data Presented at 2023 EULAR Congress Highlights How Serum CCL24 Levels Can Predict Vascular and Fibrotic Complications of Systemic Sclerosis
/PRNewswire/ -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company focused on the discovery and development of...
Source: prnewswire.com
Information on the total number of voting rights and shares
Information on the total number of voting rights and shares Mont-Saint-Guibert, Belgium, June 1, 2023, – BIOSENIC (Euronext Brussels and Paris: BIOS), the innovative company addressing unmet medical needs in in the areas of innate immunity, inflammation and organ/function repair, today announces an increa...
Source: pharmiweb.com